Dexus (DXS)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 5.750 |
|---|---|
| 52-week range | 5.300 – 7.730 |
| Return, 1 month / 3 months | +3.4% / +1.4% |
| Return, 1 year / 3 years | −19.8% / −1.6% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 20.9% |
| Worst drawdown (1 year) | -29.1% |
| Average daily value traded | 20.12M AUD |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dexus is an Australian property group based in Sydney that owns, manages and develops office, industrial and retail buildings. It earns rental income from tenants in its directly held properties and also manages property funds and portfolios on behalf of institutional and other investors. Its customers are mainly businesses and organisations that lease commercial space, and the group operates across Australia with some activity in overseas markets.
Dexus trades under the code DXS on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dexus (DXS) trades on the Australian Securities Exchange in Australia. It last closed at AUD 5.750 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 182 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.8% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.1% | ||
| From 52-week high | -25.6% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | -3.9% | ||
| 12-month return, skipping the last month | -22.4% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.1% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 20.12M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +3.4% |
| 3 months | +1.4% |
| 6 months | −3.9% |
| 1 year | −19.8% |
| 3 years | −1.6% |
| 5 years | −30.2% |
Signals
| 50-day / 200-day average | 5.668 / 5.875 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.123 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | AUD 0.1770 |
| 30 Dec 2025 | AUD 0.1930 |
| 27 Jun 2025 | AUD 0.1800 |
| 30 Dec 2024 | AUD 0.1900 |
| 27 Jun 2024 | AUD 0.2130 |
| 28 Dec 2023 | AUD 0.2670 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.